{"entity":{"type":"insider","cik":"0001683600","url":"/insider/0001683600","json_url":"/insider/0001683600.json","name":"McCain Tracey L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":10,"first":"2018-03-01","last":"2025-03-07","span_basis":"filed_date"},"name_variants":[{"name":"McCain Tracey L","source":"filing","n_filings":10,"first_seen":"2018-03-01","last_seen":"2025-03-07"}],"transactions":[{"id":4769716,"accession":"0001415889-25-007400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007400","line_url":"/filing/0001415889-25-007400#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5262.0,"shares_display":"5,262","price_per_share":88.8,"price_display":"88.80","price_state":"stated","total_value":467265.6,"total_display":"467,265.60","total_whole":"467,266","shares_owned_after":66583.0,"shares_owned_after_display":"66,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2484394,"accession":"0001415889-24-007551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007551","line_url":"/filing/0001415889-24-007551#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5194.0,"shares_display":"5,194","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":471043.86,"total_display":"471,043.86","total_whole":"471,044","shares_owned_after":60498.0,"shares_owned_after_display":"60,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":8383392,"accession":"0001415889-23-004558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004558","line_url":"/filing/0001415889-23-004558","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3322.0,"shares_display":"3,322","price_per_share":45.67819987959061,"price_display":"45.68","price_state":"stated","total_value":151742.98,"total_display":"151,742.98","total_whole":"151,743","shares_owned_after":52772.0,"shares_owned_after_display":"52,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":6315255,"accession":"0001415889-22-002736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-002736","line_url":"/filing/0001415889-22-002736#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1047.0,"shares_display":"1,047","price_per_share":56.19,"price_display":"56.19","price_state":"stated","total_value":58830.93,"total_display":"58,830.93","total_whole":"58,831","shares_owned_after":43227.0,"shares_owned_after_display":"43,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6315254,"accession":"0001415889-22-002736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002736","line_url":"/filing/0001415889-22-002736#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP AND CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":60.28,"price_display":"60.28","price_state":"stated","total_value":100486.76,"total_display":"100,486.76","total_whole":"100,487","shares_owned_after":44274.0,"shares_owned_after_display":"44,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-08","scope":"insider"},{"id":4819652,"accession":"0001179110-21-010721","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-010721","line_url":"/filing/0001179110-21-010721","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":97.298048,"price_display":"97.30","price_state":"stated","total_value":486490.24,"total_display":"486,490.24","total_whole":"486,490","shares_owned_after":34113.0,"shares_owned_after_display":"34,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-09","scope":"insider","n_lines":3},{"id":4520404,"accession":"0001179110-21-009894","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-009894","line_url":"/filing/0001179110-21-009894","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":110.5624,"price_display":"110.56","price_state":"stated","total_value":552812.0,"total_display":"552,812.00","total_whole":"552,812","shares_owned_after":34074.0,"shares_owned_after_display":"34,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-05","scope":"insider","n_lines":2},{"id":4086138,"accession":"0001179110-21-008943","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-008943","line_url":"/filing/0001179110-21-008943","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":108.8539444,"price_display":"108.85","price_state":"stated","total_value":2721348.61,"total_display":"2,721,348.61","total_whole":"2,721,349","shares_owned_after":36195.0,"shares_owned_after_display":"36,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-27","scope":"insider","n_lines":3},{"id":5151652,"accession":"0001179110-21-003009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-003009","line_url":"/filing/0001179110-21-003009","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1893.0,"shares_display":"1,893","price_per_share":86.76276809297411,"price_display":"86.76","price_state":"stated","total_value":164241.92,"total_display":"164,241.92","total_whole":"164,242","shares_owned_after":32852.0,"shares_owned_after_display":"32,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-05","scope":"insider","n_lines":2},{"id":2939092,"accession":"0001179110-20-003470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003470","line_url":"/filing/0001179110-20-003470#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":617.0,"shares_display":"617","price_per_share":51.98,"price_display":"51.98","price_state":"stated","total_value":32071.66,"total_display":"32,071.66","total_whole":"32,072","shares_owned_after":21683.0,"shares_owned_after_display":"21,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider"},{"id":6348237,"accession":"0001179110-18-003163","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-18-003163","line_url":"/filing/0001179110-18-003163","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001683600","owner_name":"McCain Tracey L","owner_display_name":"McCain Tracey L","owner_url":"/insider/0001683600","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":88.344974,"price_display":"88.34","price_state":"stated","total_value":883449.74,"total_display":"883,449.74","total_whole":"883,450","shares_owned_after":1106.0,"shares_owned_after_display":"1,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-03-01","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (EVP AND CHIEF LEGAL OFFICER)","n_filings":10,"first_seen":"2018-03-01","last_seen":"2025-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001683600","retrieved_at":"2026-08-25T07:46:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}